Prolonged treatment with N-acetylcysteine and L-arginine restores gonadal function in patients with polycistic ovary syndrome

Journal of Endocrinological Investigation

Volumn 32, Issue 11, 2009, Pages 870-872

  Masha, A ^a   Manieri, C ^a   Dinatale, S ^a   Bruno, G A ^a   Ghigo, E ^a   Martina, V ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

L arginine; N acetylcysteine; PCOS

Indexed keywords

ACETYLCYSTEINE; ARGININE; GLUCOSE; INSULIN;

ADULT; AMENORRHEA; ARTICLE; BASAL BODY TEMPERATURE; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MENSTRUAL CYCLE; MENSTRUATION; MORNING DOSAGE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; TREATMENT DURATION;

ACETYLCYSTEINE; ADOLESCENT; ADULT; AMENORRHEA; ARGININE; FEMALE; HUMANS; MENSTRUATION; OLIGOMENORRHEA; OVARY; POLYCYSTIC OVARY SYNDROME; TREATMENT OUTCOME;

EID: 77649218560     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6185     Document Type: Article

References (18)

1. Franks S. Polycystic ovarian syndrome. N Engl J Med 1995, 333: 853-61.
2. Paradisi G, Steinberg HO, Hempfling A, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001, 103: 1410-5.
3. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18: 774-800.
4. Nácul AP, Andrade CD, Schwarz P, de Bittencourt PI Jr, Spritzer PM. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Eur J Obstet Gynecol Reprod Biol 2007, 133: 191-6.
5. Goud PT, Goud AP, Diamond MP, Gonik B, Abu-Soud HM. Nitric oxide extends the oocyte temporal window for optimal fertilization. Free Radic Biol Med 2008, 45: 453-9.
6. Jablonka-Shariff A, Olson LM. The rote of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 1998, 136: 2944-54.
7. Friebe A, Koesling D. Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 2003, 93: 96-105.
8. Ignarro LJ, Edwards JC, Gruetter DY, Barry BK, Gruetter CA Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett 1980: 110: 275-8.
9. Martina V, Bruno GA, Trucco F, et al. Platelet cNOS activity is reduced in patients with IDDM and NIDDM. Thromb Haemost 1998, 79: 520-2.
10. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414: 813-20.
11. González F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006, 91: 336-40.
12. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003, 80: 123-7.
13. Martina V, Masha A, Gigliardi VR, et al. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 2008, 31: 940-4.
14. Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006, 91: 4237-45.
15. Rizk AY, Bedaiwy MA, Al-Inany HG. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 2005, 83: 367-70.
16. Kilic-Okman T, Kucuk M. N-acetyl-cysteine treatment for polycystic ovary syndrome. Int J Gynaecol Obstet 2004, 85: 296-7.
17. Fulghesu AM, Ciampelli M, Muzj G, Belosi C, et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril 2002, 77: 1128-35.
18. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006, 113: 1888-904.